April 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced the addition of two senior officers that ...

H.C. Wainwright's valuation of Microbot Medical stands at an estimated market value of $255 million, or $9 per share, which underpins the revised price target. The current market capitalization of ...

HINGHAM, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering priced at-the-market ...

HINGHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, presented for the first time the data ...

Microbot Medical (MBOT) has entered into definitive agreements for the purchase and sale of 3,788,550 shares of the Company’s common stock at a purchase price of $2.27 per share of common stock ...

Microbot Medical Inc. has successfully closed a registered direct offering of 6,103,289 shares of its common stock at a price of $2.13 per share, generating approximately $13 million in gross ...

In this article, we are going to take a look at where Microbot Medical Inc. (NASDAQ:MBOT) stands against other best rising penny stocks to buy according to analysts. The start of 2025 was ...

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm ...

BRAINTREE, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 6,103,289 ...